Caricamento pagina

Stevanato Group is Proud to Be in the COVAX Marketplace Launched by CEPI: A Platform to Accelerate COVID-19 Vaccine Production

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >Stevanato Group is Proud to Be in the COVAX Marketplace Launched by CEPI: A Platform to Accelerate COVID-19 Vaccine Production</span>

The Coalition for Epidemic Preparedness Innovations (CEPI) has launched the COVAX Marketplace, a key deliverable to accelerate the global production of COVID-19 vaccine to quickly respond to immediate market needs and improve the free flow of critical COVID-19 vaccine supplies.

The COVAX Marketplace aims to accelerate the global production of COVID-19 vaccine doses by matching existing suppliers of critical inputs with vaccine manufacturers who urgently need them to produce vaccines for fair and equitable distribution.

The project provides a secure platform for vaccine manufacturers and suppliers of critical inputs to confidentially indicate their needs or available supplies to CEPI, in its role as facilitator of the Marketplace. CEPI then identifies matching offers and requests for supplies and connects potential matches. Finally, matches negotiate and conclude the transaction between themselves, independently of the Marketplace.

Stevanato Group, after signing a key agreement with CEPI in June 2020 for the supply of glass vials, is now a key and active partner in this new project.

The COVAX Marketplace is a key deliverable of the COVAX Vaccine Manufacturing Taskforce launched to tackle COVID-19 vaccine supply challenges.

Stevanato Group
Stevanato Group

Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages.

Other news

products

Digital Holographic Microscopy (DHM®): A New Method to Characterize Silicone Coatings for Safer, Higher-Performance Drugs

1 minute read
products

ITC Syringe with Enlarged Inner Cone (EIC): Enhancing Compatibility for Intravenous (IV) Drug Delivery

1 minute read
products

The Superior Mechanical Resistance of Nexa® Vials for Improved Efficiency and Safety

1 minute read